AzTrials
AzTrials

Weaning From Mechanical VentilationPREDRICNCT02855619

Comparison of the Impact of Three Programs of Inspiratory Muscles.

A study testing Martin, Cader and EDRIC in people with Weaning From Mechanical Ventilation, run by University Hospital, Bordeaux at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ventilator-induced diaphragmatic dysfunction appears to contribute to slow weaning from mechanical ventilation. Several trials of inspiratory muscle training to facilitate weaning in intensive care have been performed, with inconsistent results, utilizing different methods of IMT in different populations. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Weaning From Mechanical Ventilation
What is being tested?
Martin, Cader and EDRIC
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
92 participants
Where
2 sitesFrance
Study dates
15 Oct 2016to 22 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient ventilated more than 18h in a controlled mode;
  • First single breathe trial of 2 hours failure;
  • Presence of sevrability criterias definied by the European consensus conference in 2007 an usually used:
  • diminution of the sedfative agents,
  • Patients with spontaneous beath in VAC mode or patient ventilated in a VSAI-PEP mode,
  • PaO2/FiO2 ≥150,
Show all 11Show fewer
  • Absence d'inotropes ou de vasopresseurs à forte dose ou dose croissante (<1mg/h),
  • SaO2 > 90% with FiO2 ≤ 50%,
  • PEP ≤ 8cmH2O,
  • Corporal température between 36°C and 39°C,
  • Glasgow Score ≥ 8.

Who cannot join

  • Age < 18 years ;
  • medically unstable;
  • Poor vital pronostic at very short term;
  • Cardiac arrest with a poor neurological prognostic;
  • Neuromuscular disease ;
  • Pneumothorax non drained ;
Show all 9Show fewer
  • Tracheostomy ;
  • Current pregnancy ;
  • Patients with guardianship or trusteeship.

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Réanimation Médicale

    Bordeaux, 33076

  • Réanimation Médicale

    Lyon, 69004

Other trials in France

About this study

Official title: Comparison of the Incidence of 3 Inspiratory Muscle Training Programs on Inspiratory Strength, on Difficult to Wean Patients in Intensive Care Unit: a Multi-centre Randomised Trial.

Ventilator-induced diaphragmatic dysfunction appears to contribute to slow weaning from mechanical ventilation. Several trials of inspiratory muscle training to facilitate weaning in intensive care have been performed, with inconsistent results, utilizing different methods of IMT in different populations.

In this study, the investigators want to compare the incidence of 3 inspiratory muscle training programs on inspiratory strength, on difficult to wean patients in intensive care unit.

Read more

This is a multi-center randomized trial not blinded with 3 parallels groups:

  • Martin's group: a threshold-based IMT is performed like used by Martin in a randomized trial in 2011, in a view of inspiratory strength increase.
  • Cader's group: a threshold-based IMT is performed like used by Cader in a randomized trial in 2010 , in a view of inspiratory endurance increase.
  • EDRIC's group: a new treshold-based IMT is performed, in a view of both inspiratory strength and endurance increase.

The investigators think that a new threshold-based IMT performed in a view of both inspiratory strength and endurance increase, is more effective and well tolerated than the 2 others protocols.

Read the detailed description

The main objective of this study is to determinate which IMT program is the most effective on the inspiratory muscle strength and endurance increase. The investigators will be able to study the impact on the weaning time of IMT performed with the best protocol.

The investigators are going to conduct a randomized trial with intention-to-treat analysis. Following 18h of invasive mechanical ventilation in a controlled mode, the failure of the first single breathe trial of 2 hours and the presence of sevrability criterias defined by the European consensus conference in 2007, 88 participants will be included. Participants will be randomizesd to receive one of the 3 protocols of IMT, 2 times per day, 7 days per week, from the inclusion to the extubation.

The ratio of randomization will be 1:1:2 for a better evaluation of EDRIC's group wich propose a new IMT protocol.

Being tested
Martin, Cader, EDRIC
Keywords
inspiratory muscles training programs, Ventilator-induced diaphragmatic dysfunction, Weaning, Intensive care unit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MartinProcedure or surgery

    The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance to the higher resistance tolerated by the patient in a set of 6 breaths. Participant repeats 4 sets of 6-10 breaths with 2 minutes of resting with mechanical ventilation between each set.

    This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2<150).

  • CaderProcedure or surgery

    The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance to 30% of the Maximal Inspiratory Pressure initially recorded the day of the inclusion. Participant breaths against this resistance during 5 minutes. The resistance is daily increased of 10 % to the higher tolerated.

    This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2<150).

  • EDRICProcedure or surgery

    The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance at 30% of the Maximal Inspiratory Pressure of the day for the first set of 20 breaths with a resistance 's increasment of 10% at each set. Participant repeats 4 sets of 20 breaths with 2 minutes of resting with mechanical ventilation between each set.

    This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2<150).

Study groups in NCT02855619
Study groupRoleWhat they receive
MartinActive comparatorA threshold-based IMT is performed like used by Martin in a randomized trial in 2011, in a view of inspiratory strength increase.
Receives: Procedure: Martin
CaderActive comparatorA threshold-based IMT is performed like used by Cader in a randomized trial in 2012, in a view of inspiratory endurance increase.
Receives: Procedure: Cader
EDRICExperimentalA new threshold-based IMT is performed, in a view of both inspiratory strength and endurance increase.
Receives: Procedure: EDRIC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal Inspiratory Pressure score (inspiratory muscle strength index) performed by an external electronic device connected with a unidirectional valve.

    Measured: Baseline and up to day 25

Secondary outcomes (5)
  1. Peak Pressure (inspiratory muscle endurance index) performed by an incremental threshold test.

    Measured: Baseline and up to day 25

  2. Duration of the weaning period

    Measured: up to day 25

  3. ICU lengh of stay

    Measured: Day 30

  4. Weaning success

    Measured: up to day 27

  5. Adverse events

    Measured: Day 30

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2016 (estimated)
  2. Study start15 Oct 2016
  3. Primary completion22 Feb 2020
  4. Study completion22 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
92 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02855619
Sponsor's protocol ID
CHUBX2015/25
Acronym
PREDRIC
Status last verified
May 2020
First submitted
28 Jul 2016
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Reginault T, Martinez Alejos R, Coueron R, Burle JF, Boyer A, Frison E, Vargas F. Impacts of three inspiratory muscle training programs on inspiratory muscles strength and endurance among intubated and mechanically ventilated patients with difficult weaning: a multicentre randomised controlled trial. J Intensive Care. 2024 Jul 25;12(1):28. doi: 10.1186/s40560-024-00741-3.

    PubMed 39049092

Questions about this trial

What is this clinical trial studying?

A study testing Martin, Cader and EDRIC in people with Weaning From Mechanical Ventilation, run by University Hospital, Bordeaux at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal Inspiratory Pressure score (inspiratory muscle strength index) performed by an external electronic device connected with a unidirectional valve. (time frame: Baseline and up to day 25). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02855619, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in